Fastest Drug Developers Consistently Outperform Their Peers, Generating Substantially Higher Revenue And Cost Savings, According To The Tufts Center for the Study of Drug Development

BOSTON, MA -- (MARKET WIRE) -- September 13, 2006 -- Drug companies that develop and launch new products faster than their peers perform consistently better across a number of dimensions, earn higher revenues, and have lower development costs, according to a newly completed analysis from the Tufts Center for the Study of Drug Development.